Global cell viability assays market expected to generate around USD 5.12 billion by 2025, at a CAGR of around 8.3% between 2019 and 2025. The growing occurrence of chronic diseases is fueling the research activities to treat these diseases, which is driving the global cell viability assays market.

Sarasota, FL -- (SBWire) -- 04/09/2019 --Zion Market Research has published a new report titled "Cell Viability Assays Market by Product (Consumables and Instruments), by Application (Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications, and Others), and by End-User (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Diagnostic Laboratories, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025". According to the report, the global cell viability assays market was valued at approximately USD 2.93 billion in 2018 and is expected to generate around USD 5.12 billion by 2025, at a CAGR of around 8.3% between 2019 and 2025.

Download Free PDF Research Report Brochure @ https://www.zionmarketresearch.com/requestbrochure/cell-viability-assays-market

Cell viability assay is an assay technique where the effect of a compound on cell activity is checked. This is generally used during drug development procedures to check whether the developed drug is useful for the treatment of diseases. The growing occurrence of chronic diseases is fueling the research activities to treat these diseases, which is driving the global cell viability assays market. The growing prevalence of chronic and infectious diseases is fueling the growth of the global cell viability assays market. The growing investments made by the government for drug development, increasing the cell-based research activities, and the development of technologically advanced products for cell-based assays. However, the high cost of the cell viability assay instruments may hinder the cell viability assays market in the future.

The global cell viability assays market is divided into product, application, and end-user. By product, the cell viability assays market is bifurcated into instruments and consumables. The consumables segment includes assay kits, reagents, and microplates. The assay kits segment include resazurin cell viability assay kits, tetrazolium reduction assay kits, calcein-AM cell viability assay kits, and others. The instruments segment includes cell imaging and analysis systems, automated cell counters, spectrophotometers, and flow cytometers. The consumables segment is anticipated to dominate the cell viability assays market globally in the future, due to the growing demand for assay kits and reagents in research activities related to a cell. The growing cell-based research is also fueling the growth of the consumables segment in global cell viability assays market. By application, the market is divided into stem cell research, clinical and diagnostic applications, basic research, drug discovery and development, and others. The drug discovery and development segment held the largest share of the global cell viability assays market in 2018, owing to the increasing prevalence of infectious and chronic diseases. By end-user, the market is segmented into hospitals and diagnostic laboratories, pharmaceutical and biotechnology companies, academic and research institutes, and others. Pharmaceutical and biotechnological companies dominated the market in 2018, owing to the rising establishments of these companies and increasing research activities conducted by these companies.

By region, North America is predicted to lead the global cell viability assays market in the upcoming years, owing to an increase in the prevalence of infectious diseases, growing research activities, and developed research and clinical laboratories. The Asia Pacific the global cell viability assays market is expected to show the highest growth in the future, owing to the presence of a large patient pool, the high prevalence of chronic and infectious diseases, and increase in research activities related to the development of drugs and pharmaceutical products.

Request Free Sample Report @ https://www.zionmarketresearch.com/sample/cell-viability-assays-market

Some key players of the global cell viability assays market are Bio-Rad Laboratories, Inc., GE Healthcare, PerkinElmer, Danaher Corporation, Promega Corporation, Thermo Fischer Scientific, BioTek Instruments, Biotium, Merck, Becton, Dickinson, and Company, and G-Biosciences, among others.

This report segments the global cell viability assays market as follows:

Global Cell Viability Assays Market: Product Analysis

Consumables
Assay Kits
Tetrazolium Reduction Assay Kits
Resazurin Cell Viability Assay Kits
Calcein-AM Cell Viability Assay Kits
Others
Reagents
Microplates
Instruments
Automated Cell Counters
Spectrophotometers
Cell Imaging and Analysis Systems
Flow Cytometers

Global Cell Viability Assays Market: Application Analysis

Basic Research
Stem Cell Research
Drug Discovery and Development
Clinical and Diagnostic Applications
Others

Global Cell Viability Assays Market: End-User Analysis

Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
Hospitals and Diagnostic Laboratories
Others

Inquiry more about this report @ https://www.zionmarketresearch.com/inquiry/proteomics-market

Global Cell Viability Assays Market: Regional Analysis

North America
The U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
The Middle East and Africa